Evidence map›Paper›PMID 17553960›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.

Francine M Benes, Benjamin Lim, David Matzilevich, John P Walsh, Sivan Subburaju, Martin Minns

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 247 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
247citing papers in PubMed, 4 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

247 citing papers in PubMed, 4 syntheses or guidelines pooled it, 483 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

187 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Francine M BenesProgram in Structural and Molecular Neuroscience, McLean Hospital, Belmont, MA 02178, USA. fbenes@mclean.harvard.edu
Benjamin Lim
David Matzilevich
John P Walsh
Sivan Subburaju
Martin Minns
Harvard University · US

Funding

Limbic Lobe in Schizophrenia and Bipolar DisorderR37MH042261 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 2002 to 2011
$4.7M
BRAIN TISSUE RESOURCE OFR NEUROPSYCHIATRIC RESEARCHR01MH031862 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 1985 to 2002
$3.6M
QUANTITATIVE CYTOARCHITECTURAL STUDIES OF SCHIZOPHRENIAR01MH042261 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 1987 to 2001
$559k
HIPPOCAMPAL GENE EXPRESSION IN SCHIZOPHRENIAR21MH062822 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 2000 to 2001
$395k
NIMH NIH HHS MH 31862NIMH NIH HHS MH 42261NIMH NIH HHS MH 62822NIMH NIH HHS R01 MH042261NIMH NIH HHS R37 MH042261
6 · The paper itself

Abstract

GABAergic dysfunction is present in the hippocampus in schizophrenia (SZ) and bipolar disorder (BD). The trisynaptic pathway was "deconstructed" into various layers of sectors CA3/2 and CA1 and gene expression profiling performed. Network association analysis was used to uncover genes that may be related to regulation of glutamate decarboxylase 67 (GAD(67)), a marker for this system that has been found by many studies to show decreased expression in SZs and BDs. The most striking change was a down-regulation of GAD(67) in the stratum oriens (SO) of CA2/3 in both groups; CA1 only showed changes in the SO of schizophrenics. The network generated for GAD(67) contained 25 genes involved in the regulation of kainate receptors, TGF-beta and Wnt signaling, as well as transcription factors involved in cell growth and differentiation. In SZs, IL-1beta, (GRIK2/3), TGF-beta2, TGF-betaR1, histone deacetylase 1 (HDAC1), death associated protein (DAXX), and cyclin D2 (CCND2) were all significantly up-regulated, whereas in BDs, PAX5, Runx2, LEF1, TLE1, and CCND2 were significantly down-regulated. In the SO of CA1 of BDs, where GAD67 showed no expression change, TGF-beta and Wnt signaling genes were all up-regulated, but other transcription factors showed no change in expression. In other layers/sectors, BDs showed no expression changes in these GAD(67) network genes. Overall, these results are consistent with the hypothesis that decreased expression of GAD(67) may be associated with an epigenetic mechanism in SZ. In BD, however, a suppression of transcription factors involved in cell differentiation may contribute to GABA dysfunction.

Indexed as

Gene Expression RegulationBipolar DisorderCase-Control StudiesDown-RegulationFemalegamma-Aminobutyric AcidGene Expression ProfilingGlutamate DecarboxylaseHippocampusHumansIsoenzymesMaleModels, BiologicalPhenotypeRNA, MessengerSchizophreniagamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 1IsoenzymesRNA, Messenger

Identifiers

PMID17553960
PMCPMC1888575
OpenAlexW2013074165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.